Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage

被引：0
|
作者：
Edwin Uriel Suárez
Miguel Ángel Piris
Socorro María Rodríguez-Pinilla
Juan F. García
José Luis López-Lorenzo
Javier Cornago-Navascués
Rocío Salgado-Sánchez
Tamara Castaño-Bonilla
Raquel Mata-Serna
Juan M. Alonso-Domínguez
Pilar Llamas
机构：
[1] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Hematology
[2] Universidad Autónoma de Madrid,Department of Pathology
[3] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Pathology
[4] Universidad Autónoma de Madrid,undefined
[5] MD Anderson Cancer Center,undefined
来源：
Annals of Hematology | 2024年 / 103卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1797 / 1799
页数：2
相关论文
共 50 条
  • [21] Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes
    Toyama, Kohtaro
    Karasawa, Masamitsu
    Yokohama, Akihiko
    Mitsui, Takeki
    Uchiumi, Hideki
    Saitoh, Takayuki
    Handa, Hiroshi
    Murakami, Hirokazu
    Nojima, Yoshihisa
    Tsukamoto, Norifumi
    INTERNAL MEDICINE, 2011, 50 (21) : 2557 - 2561
  • [22] Portal vein thrombosis as the presenting manifestation of JAK2 positive myeloproliferative neoplasm
    Jeon, Won Jin
    Mehta, Akhil
    Hudson, Jessica
    Castillo, Dani Ran
    Wang, Jun
    Nguyen, Anthony
    Akhtari, Mojtaba
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 (05): : 457 - 461
  • [23] Acute leukemia of ambiguous lineage: As ambiguous as it gets?
    Redmond, Norma
    Bolinger, Carol
    Murphy, Kathleen
    Czader, Magdalena
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2006, 70B (05) : 374 - 374
  • [24] Unique differences in clinical presentation between JAK2 splanchnic vein thrombosis and WHO defined JAK2 myeloproliferative neoplasm
    George, S.
    MacLeod, J.
    Francis, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 86 - 86
  • [25] A p53-JAK-STAT connection involved in myeloproliferative neoplasm pathogenesis and progression to secondary acute myeloid leukemia
    Goyal, Harsh
    Chachoua, Ilyas
    Pecquet, Christian
    Vainchenker, William
    Constantinescu, Stefan N.
    BLOOD REVIEWS, 2020, 42
  • [26] Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript
    Duployez, Nicolas
    Nibourel, Olivier
    Ducourneau, Benoit
    Grardel, Nathalie
    Boyer, Thomas
    Bories, Claire
    Darre, Stephane
    Coiteux, Valerie
    Berthon, Celine
    Preudhomme, Claude
    Roche-Lestienne, Catherine
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (04) : 399 - 402
  • [27] Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2
    E Grundschober
    A Hoelbl-Kovacic
    N Bhagwat
    B Kovacic
    R Scheicher
    E Eckelhart
    K Kollmann
    M Keller
    F Grebien
    K-U Wagner
    R L Levine
    V Sexl
    Leukemia, 2014, 28 : 1918 - 1922
  • [28] BCR/ABL-negative chronic myeloproliferative disorders -: JAK2 mutation and beyond
    Chang, Chung-Che
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (08) : 1123 - 1125
  • [29] QUANTITATIVE PROTEOME HETEROGENEITY IN MYELOPROLIFERATIVE NEOPLASM SUBTYPES AND ASSOCIATION WITH JAK2 MUTATION STATUS
    Yuste, N. Socoro
    Vladan, C. P.
    Mondet, J.
    Plo, I.
    Mossuz, P.
    HAEMATOLOGICA, 2017, 102 : 276 - 276
  • [30] AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells
    Pearson, Stella
    Blance, Rognvald
    Somervaille, Tim C. P.
    Whetton, Anthony D.
    Pierce, Andrew
    HEMASPHERE, 2019, 3 (03):
12345